NEW YORK (360Dx) – Lyme disease and tick-borne diseases in general as a diagnostic testing segment is garnering greater interest from commercial diagnostic developers of late, driven in part by the increasing prevalence of such infections in the US.

Tick-borne diseases have had a large concentration in the Northeast, but the parasites are starting to move west, carrying disease with them, and countries in Europe are also reporting a lift in prevalence, Piper Jaffray research analyst William Quirk said in an interview.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.